Annerén Cecilia
Department of Molecular and Cellular Biology, Harvard University, Cambridge, USA.
Lakartidningen. 2002 May 23;99(21):2394-5, 2398-9.
Insulin dependent diabetes mellitus (type 1-diabetes) results from a selective destruction of the insulin producing beta cells and a limited capacity of the remaining cells to regenerate in a compensatory manner. Increased knowledge of the factors involved in the regulation of beta-cell growth may lead to new ways of forming beta cells that in combination with selective immunosuppression could be used for treatment of type 1 diabetes. Physiological and pathophysiological conditions that induce beta-cell growth, different factors that have been implicated to regulate these processes and future perspectives concerning treatment of type 1 diabetes by expanding the beta-cell mass is discussed in this review article.
胰岛素依赖型糖尿病(1型糖尿病)是由于产生胰岛素的β细胞被选择性破坏,以及剩余细胞以代偿方式再生的能力有限所致。对参与β细胞生长调节的因素的更多了解可能会带来形成β细胞的新方法,这些方法与选择性免疫抑制相结合可用于治疗1型糖尿病。本文综述了诱导β细胞生长的生理和病理生理条件、涉及调节这些过程的不同因素以及通过增加β细胞数量来治疗1型糖尿病的未来前景。